The Centers for Medicare & Medicaid Services recently issued a memo clarifying its ligature risk policy, which pertains to environmental safeguards for patients at risk of harm to self or others. The agency expects to release comprehensive guidance for state survey agencies and accrediting organizations in the next six months. Meanwhile, the accrediting body or state agency has authority to determine the level of citation for ligature deficiencies based on its expert opinion, CMS said. According to the clarifying memo, the focus for a ligature “resistant” or ligature “free” environment is primarily aimed at psychiatric hospitals and units, and does not apply to non-psychiatric units of acute care hospitals.

Related News Articles

Headline
The Food and Drug Administration sent a warning letter to Philips last month due to quality violations found at three of its medical device facilities earlier…
Blog
Public
Cross-industry insights and new technology are helping HCA Healthcare reduce risk, improve outcomes and lead the future of high-reliability careFor Randy Fagin…
Headline
The Food and Drug Administration has identified a Class I recall of Abiomed Automated Impella Controllers due to the potential for serious injury or death. The…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The Food and Drug Administration has identified Class I recalls for the following products due to the potential for serious injury or death:Certain lots of…
Headline
Randy Fagin, M.D., chief quality officer at HCA Healthcare, shares insights into the organization’s bold approach to improving safety outcomes. From piloting…